Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) EPS (Basic) (2016 - 2025)

HealthLynked (HLYK) has disclosed EPS (Basic) for 10 consecutive years, with -$0.3 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) rose 82.66% to -$0.3 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.42, a 181.14% increase, with the full-year FY2024 number at -$0.02, down 100.0% from a year prior.
  • EPS (Basic) was -$0.3 for Q3 2025 at HealthLynked, down from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.72 in Q4 2024 to a low of -$1.73 in Q3 2024.
  • A 5-year average of -$0.02 and a median of -$0.01 in 2022 define the central range for EPS (Basic).
  • Biggest YoY gain for EPS (Basic) was 17300.0% in 2024; the steepest drop was 262498.99% in 2024.
  • HealthLynked's EPS (Basic) stood at -$0.01 in 2021, then crashed by 100.0% to -$0.02 in 2022, then skyrocketed by 50.0% to -$0.01 in 2023, then soared by 17300.0% to $1.72 in 2024, then tumbled by 117.44% to -$0.3 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's EPS (Basic) are -$0.3 (Q3 2025), -$0.0 (Q2 2025), and -$0.0 (Q1 2025).